Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Toho Holdings CoFRA:TON +1.96%82 3-Year EBITDA Growth Rate is 11.00% as of Mar. 2026, which is 104% above its 10-year median of 5.40. GuruFocus rates FRA:TON with a GF Score™ of 82/100 and a GF Value™ of €26.00. The stock has 3 warning signs investors should review. Among 105 Medical Distribution companies, Toho Holdings Co ranks better than 61.9% on this metric.
During the past 12 months, Toho Holdings Co's average EBITDA Per Share Growth Rate was -0.40% per year.
During the past 3 years, the average EBITDA Per Share Growth Rate was 11.00% per year.
During the past 5 years, the average EBITDA Per Share Growth Rate was 16.20% per year.
During the past 10 years, the average EBITDA Per Share Growth Rate was 1.00% per year.
Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average EBITDA per share growth rate.
During the past 13 years, the highest 3-Year average EBITDA Per Share Growth Rate of Toho Holdings Co was 87.50% per year. The lowest was -33.00% per year. And the median was 5.40% per year.
Toho Holdings Co (FRA:TON) 3-Year EBITDA Growth Rate Explanation
EBITDA per Share is the amount of Earnings Before Interest, Taxes, Depreciation, and Amortization (EBITDA) per outstanding share of the company's stock.
Earnings Before Interest, Taxes, Depreciation, and Amortization (EBITDA) is what the company earns before it expenses interest, taxes, depreciation and amortization.
Toho Holdings Co 3-Year EBITDA Growth Rate Related Terms
FRA:TON vs MCK, COR, CAH: 3-Year EBITDA Growth Rate Comparison
For the Medical Distribution subindustry, Toho Holdings Co's 3-Year EBITDA Growth Rate, along with its competitors' market caps and 3-Year EBITDA Growth Rate data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Toho Holdings Co 3-Year EBITDA Growth Rate vs Medical Distribution Industry
For the Medical Distribution industry and Healthcare sector, Toho Holdings Co's 3-Year EBITDA Growth Rate distribution charts can be found below:
* The bar in red indicates where Toho Holdings Co's 3-Year EBITDA Growth Rate falls into.
Toho Holdings Co 3-Year EBITDA Growth Rate Calculation
This is the 3-year average growth rate of EBITDA per Share. The growth rate is calculated using exponential compounding based on the latest four year annual data.
Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average EBITDA per share growth rate.
What does a 3-Year EBITDA Growth Rate of 11.00% mean?
Toho Holdings Co (FRA:TON) has a 3-Year EBITDA Growth Rate of 11.00% as of Mar. 2026. 3-Year EBITDA Growth Rate is the 3-year average growth rate of EBITDA per share. View historical data for Toho Holdings Co and its competitors. This is 104% above median its historical median of 5.40. According to the industry distribution chart, Toho Holdings Co ranks #40 out of 105 companies in the Medical Distribution industry, placing it in the top 38.1%.
Is Toho Holdings Co's 3-Year EBITDA Growth Rate too high?
Toho Holdings Co's current 3-Year EBITDA Growth Rate of 11.00% is 104% above median its 10-year median of 5.40. The Medical Distribution industry median 3-Year EBITDA Growth Rate is 5.40. Toho Holdings Co's value of 11.00% is 103.7% above this industry median. Based on the distribution chart, Toho Holdings Co ranks #40 out of 105 companies in the Medical Distribution industry, which is above the industry midpoint. Overall, Toho Holdings Co has a GF Score™ of 82/100, reflecting its overall financial health beyond just this single metric.
How does Toho Holdings Co's 3-Year EBITDA Growth Rate compare to MCK and COR?
According to the Medical Distribution industry distribution chart, Toho Holdings Co ranks #40 out of 105 companies for 3-Year EBITDA Growth Rate. This puts Toho Holdings Co in the upper half of its industry. The industry median 3-Year EBITDA Growth Rate is 5.40. Toho Holdings Co's value of 11.00% is 103.7% above this benchmark. While the company's 10-year median is 5.40 vs. the industry median of 5.40, Toho Holdings Co has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good 3-Year EBITDA Growth Rate for a Medical Distribution company?
The median 3-Year EBITDA Growth Rate among Medical Distribution companies is 5.40, based on 105 companies in the industry. Companies in the top quartile (top 25%) have a 3-Year EBITDA Growth Rate significantly above this median, while those in the bottom quartile fall well below. However, 3-Year EBITDA Growth Rate should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Toho Holdings Co's current 3-Year EBITDA Growth Rate of 11.00% is 103.7% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high 3-Year EBITDA Growth Rate mean?
A high 3-Year EBITDA Growth Rate can signal that a stock is expensive relative to its fundamentals. 3-Year EBITDA Growth Rate is the 3-year average growth rate of EBITDA per share. View historical data for Toho Holdings Co and its competitors. For the Medical Distribution industry, the median 3-Year EBITDA Growth Rate is 5.40 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Toho Holdings Co's current 3-Year EBITDA Growth Rate is 11.00%, which is 104% above median its own 10-year median of 5.40. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Toho Holdings Co stock overvalued right now?
Toho Holdings Co (FRA:TON) has a current 3-Year EBITDA Growth Rate of 11.00%. The stock's GF Value™ is €26.00, compared to a current price of €20.80 — trading 20% below its estimated fair value. The current 3-Year EBITDA Growth Rate is 11.00%, which is 104% above median its 10-year median of 5.40 and 103.7% above the Medical Distribution industry median of 5.40. Toho Holdings Co's overall GF Score™ is 82/100 with 3 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is 3-Year EBITDA Growth Rate calculated?
3-Year EBITDA Growth Rate is calculated from a company's financial statements. For Toho Holdings Co (FRA:TON), the current 3-Year EBITDA Growth Rate is 11.00% as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Toho Holdings Co (FRA:TON) Overvalued in 2026?
Based on GuruFocus' analysis, Toho Holdings Co stock appears to be undervalued.
The current stock price of €20.80 is trading 20% below its estimated GF Value™ of €26.00.
Key valuation signals for FRA:TON:
3-Year EBITDA Growth Rate: 11.00% (104% above median its 10-year median of 5.40)
GF Value™: €26.00 vs. price of €20.80 (20% below fair value)
Industry Position: 103.7% above the Medical Distribution median (#40 of 105)
No single metric tells the full story. See the FRA:TON stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Toho Holdings Co Ltd is a specialty and generic drug manufacturing company. The company's business includes pharmaceutical wholesaling and pharmacy dispensing. It also maintains a site-management organization business that assists a variety of medical establishments, ranging from large medical institutions to private clinics, with a wide range of clinical trials under contract. The company supports medical institutions suitable for respective trials to improve the quality and speed of clinical trials. It generates additional revenue through software sales to medical institutions.
82GF Score
Get the complete analysis for FRA:TON
3-Year EBITDA Growth Rate is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
FRA:TON has been successfully added to your 
